| scholarly article | Q13442814 |
| P50 | author | Marla Dubinsky | Q30501395 |
| Dermot McGovern | Q59702746 | ||
| Jerome I Rotter | Q59813011 | ||
| Kent D Taylor | Q89467237 | ||
| P2093 | author name string | Jordan Brown | |
| Gordon D Brown | |||
| Iliyan D Iliev | |||
| Vincent A Funari | |||
| Samuel P Strom | |||
| Hanlin L Wang | |||
| Christopher N Reyes | |||
| Courtney A Becker | |||
| Phillip R Fleshner | |||
| David M Underhill | |||
| Quoclinh Nguyen | |||
| P2860 | cites work | Novel Anti-Glycan Antibodies Related to Inflammatory Bowel Disease Diagnosis and Phenotype | Q22251117 |
| Dectin-1 is an extracellular pathogen sensor for the induction and processing of IL-1β via a noncanonical caspase-8 inflammasome | Q24303046 | ||
| Enterotypes of the human gut microbiome | Q24489818 | ||
| QIIME allows analysis of high-throughput community sequencing data | Q24616873 | ||
| A human gut microbial gene catalogue established by metagenomic sequencing | Q24618931 | ||
| Human dectin-1 deficiency and mucocutaneous fungal infections | Q24645008 | ||
| A homozygous CARD9 mutation in a family with susceptibility to fungal infections | Q24658090 | ||
| Multiple sequence alignment with the Clustal series of programs | Q24672842 | ||
| BLAT—The BLAST-Like Alignment Tool | Q24682492 | ||
| A New Statistical Method for Haplotype Reconstruction from Population Data | Q27860495 | ||
| The Sequence Alignment/Map format and SAMtools | Q27860966 | ||
| Genome-wide association identifies multiple ulcerative colitis susceptibility loci | Q27865246 | ||
| The value of serologic markers in indeterminate colitis: a prospective follow-up study | Q28216203 | ||
| Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity | Q28512778 | ||
| Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium: Design of prospective meta-analyses of genome-wide association studies from 5 cohorts | Q28751965 | ||
| Genetic predictors of medically refractory ulcerative colitis | Q28943368 | ||
| Genome-wide association study for ulcerative colitis identifies risk loci at 7q22 and 22q13 (IL17REL). | Q29417124 | ||
| A comparison of bayesian methods for haplotype reconstruction from population genotype data | Q29547566 | ||
| The Cardiovascular Health Study: design and rationale | Q29614874 | ||
| Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5 | Q29615053 | ||
| NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis | Q29616155 | ||
| Host-mediated inflammation disrupts the intestinal microbiota and promotes the overgrowth of Enterobacteriaceae | Q33306722 | ||
| Fungi and inflammatory bowel diseases: Alterations of composition and diversity | Q33347197 | ||
| Characterization of the oral fungal microbiome (mycobiome) in healthy individuals | Q33523794 | ||
| Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. | Q33937171 | ||
| Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis | Q34187114 | ||
| Abundant and diverse fungal microbiota in the murine intestine | Q34315970 | ||
| Dectin-1 is required for beta-glucan recognition and control of fungal infection | Q35837153 | ||
| Accurate taxonomy assignments from 16S rRNA sequences produced by highly parallel pyrosequencers | Q36935436 | ||
| Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis | Q37106755 | ||
| Recent progress in understanding the phenotype and function of intestinal dendritic cells and macrophages | Q37349757 | ||
| The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans | Q42385375 | ||
| Gut CD103+ dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. | Q43081763 | ||
| A software pipeline for processing and identification of fungal ITS sequences | Q43171943 | ||
| A pyrosequencing study in twins shows that gastrointestinal microbial profiles vary with inflammatory bowel disease phenotypes | Q43883077 | ||
| Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. | Q46040098 | ||
| Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens | Q46134666 | ||
| Colonization of Mice byCandida albicansIs Promoted by Chemically Induced Colitis and Augments Inflammatory Responses through Galectin‐3 | Q56019292 | ||
| Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17 | Q56880713 | ||
| P433 | issue | 6086 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | colitis | Q2453464 |
| P304 | page(s) | 1314-1317 | |
| P577 | publication date | 2012-06-06 | |
| P1433 | published in | Science | Q192864 |
| P1476 | title | Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis | |
| P478 | volume | 336 |
| Q92688020 | "Candida Albicans Interactions With The Host: Crossing The Intestinal Epithelial Barrier" |
| Q61666960 | "Nature versus Nurture" and the indigenous microbiome |
| Q61449824 | A Fungal World: Could the Gut Mycobiome Be Involved in Neurological Disease? |
| Q64056532 | A Soluble Immune Effector Binds Both Fungi and Bacteria via Separate Functional Domains |
| Q52580370 | A System Biology Perspective on Environment-Host-Microbe Interactions. |
| Q40301248 | A member of the gut mycobiota modulates host purine metabolism exacerbating colitis in mice. |
| Q42094298 | A mutated B cell chronic lymphocytic leukemia subset that recognizes and responds to fungi. |
| Q35832535 | Activation of HIF-1α and LL-37 by commensal bacteria inhibits Candida albicans colonization |
| Q38806236 | Adaptation of Candida albicans to commensalism in the gut. |
| Q35164257 | Adaptive immunity to fungi. |
| Q38194867 | Advances in IBD genetics |
| Q41872070 | Aging and the human gut microbiota-from correlation to causality |
| Q47127865 | Alterations in the mucosa-associated fungal microbiota in patients with ulcerative colitis |
| Q64120380 | Altered Bacterial-Fungal Interkingdom Networks in the Guts of Ankylosing Spondylitis Patients |
| Q90628238 | Altered Immunity of Laboratory Mice in the Natural Environment Is Associated with Fungal Colonization |
| Q37139967 | Altered gut microbiota in Rett syndrome |
| Q26766720 | An Omics Perspective on Candida Infections: Toward Next-Generation Diagnosis and Therapy |
| Q37737823 | An expanding stage for commensal microbes in host immune regulation |
| Q38121585 | An immunological link between Candida albicans colonization and Crohn's disease. |
| Q35631737 | An integrative view of microbiome-host interactions in inflammatory bowel diseases |
| Q34615088 | Anaerobic bacteria grow within Candida albicans biofilms and induce biofilm formation in suspension cultures |
| Q26995807 | Analysis of the human gut microbiome and association with disease |
| Q33870482 | Animal models for candidiasis |
| Q37111268 | Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis |
| Q88693847 | Antifungal Innate Immunity: A Perspective from the Last 10 Years |
| Q43733156 | Antigen-specific expansion of human regulatory T cells as a major tolerance mechanism against mucosal fungi. |
| Q58614336 | Antimicrobial proteins: intestinal guards to protect against liver disease |
| Q29994477 | Application of the adverse outcome pathway (AOP) concept to structure the available in vivo and in vitro mechanistic data for allergic sensitization to food proteins |
| Q31120665 | Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents |
| Q27682064 | Architecture of a single membrane spanning cytochrome P450 suggests constraints that orient the catalytic domain relative to a bilayer |
| Q89431949 | Aryl hydrocarbon receptor/IL-22/Stat3 signaling pathway is involved in the modulation of intestinal mucosa antimicrobial molecules by commensal microbiota in mice |
| Q35309849 | Autophagy, viruses, and intestinal immunity |
| Q38099513 | Autophagy: a new target or an old strategy for the treatment of Crohn's disease? |
| Q28278714 | Bacteriome and Mycobiome Interactions Underscore Microbial Dysbiosis in Familial Crohn's Disease |
| Q41622001 | Batf3 deficiency is not critical for the generation of CD8α⁺ dendritic cells |
| Q38567197 | Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida species |
| Q28534361 | Bruton's Tyrosine Kinase (BTK) and Vav1 contribute to Dectin1-dependent phagocytosis of Candida albicans in macrophages |
| Q33790391 | C-Terminal Domain of Hemocyanin, a Major Antimicrobial Protein from Litopenaeus vannamei: Structural Homology with Immunoglobulins and Molecular Diversity |
| Q50351148 | C-Type Lectin-Like Receptors As Emerging Orchestrators of Sterile Inflammation Represent Potential Therapeutic Targets |
| Q38120558 | C-type lectin receptors orchestrate antifungal immunity |
| Q88182685 | C-type lectins in immunity and homeostasis |
| Q38305222 | C-type lectins in immunity: recent developments |
| Q39045109 | C-type lectins: their network and roles in pathogen recognition and immunity |
| Q91868621 | CAR T Cells Beyond Cancer: Hope for Immunomodulatory Therapy of Infectious Diseases |
| Q37380370 | CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands |
| Q38896152 | CD14 is associated with biliary stricture formation. |
| Q36367511 | CD4(+) T-cell survival in the GI tract requires dectin-1 during fungal infection |
| Q48257612 | CX3CR1+ mononuclear phagocytes control immunity to intestinal fungi. |
| Q34057053 | Calcineurin controls hyphal growth, virulence, and drug tolerance of Candida tropicalis |
| Q59072636 | Candida Immunity |
| Q36080619 | Candida albicans Pathogenesis: Fitting within the Host-Microbe Damage Response Framework |
| Q42869350 | Candida albicans and Enterococcus faecalis in the gut: synergy in commensalism? |
| Q35535803 | Candida albicans colonization and dissemination from the murine gastrointestinal tract: the influence of morphology and Th17 immunity |
| Q34633866 | Candida albicans commensalism and pathogenicity are intertwined traits directed by a tightly knit transcriptional regulatory circuit |
| Q34492985 | Candida albicans commensalism in the gastrointestinal tract |
| Q36748239 | Candida albicans primes TLR cytokine responses through a Dectin-1/Raf-1-mediated pathway |
| Q38130314 | Candida albicans, plasticity and pathogenesis |
| Q37194665 | Card9 mediates intestinal epithelial cell restitution, T-helper 17 responses, and control of bacterial infection in mice |
| Q40183418 | Card9-dependent IL-1β regulates IL-22 production from group 3 innate lymphoid cells and promotes colitis-associated cancer |
| Q55645608 | Caspase recruitment domain (CARD) family (CARD9, CARD10, CARD11, CARD14 and CARD15) are increased during active inflammation in patients with inflammatory bowel disease. |
| Q28072839 | Cell biology of Candida albicans-host interactions |
| Q92969533 | Cellular and molecular mechanisms of antifungal innate immunity at epithelial barriers: The role of C-type lectin receptors |
| Q35651341 | Changes in the composition of intestinal fungi and their role in mice with dextran sulfate sodium-induced colitis |
| Q35535730 | Characterization of Bacterial and Fungal Microbiome in Children with Hirschsprung Disease with and without a History of Enterocolitis: A Multicenter Study |
| Q37222992 | Clinical Effects of Gamma-Radiation-Resistant Aspergillus sydowii on Germ-Free Mice Immunologically Prone to Inflammatory Bowel Disease |
| Q35169025 | Colitis-associated neoplasia: molecular basis and clinical translation |
| Q36764678 | Colorectal cancer: looking for answers in the microbiota |
| Q58802527 | Combined bacterial and fungal intestinal microbiota analyses: Impact of storage conditions and DNA extraction protocols |
| Q94445771 | Combined bacterial and fungal targeted amplicon sequencing of respiratory samples: Does the DNA extraction method matter? |
| Q92359266 | Commensal Candida albicans Positively Calibrates Systemic Th17 Immunological Responses |
| Q46254511 | Commensal Fungi Recapitulate the Protective Benefits of Intestinal Bacteria |
| Q52759357 | Commensal Fungi in Health and Disease. |
| Q35458229 | Commensal microbes and interferon-λ determine persistence of enteric murine norovirus infection |
| Q33971938 | Commensal microbes drive intestinal inflammation by IL-17-producing CD4+ T cells through ICOSL and OX40L costimulation in the absence of B7-1 and B7-2. |
| Q92310217 | Comparison of Japanese and Indian intestinal microbiota shows diet-dependent interaction between bacteria and fungi |
| Q37352741 | Compartmentalized and systemic control of tissue immunity by commensals |
| Q35113366 | Complementary amplicon-based genomic approaches for the study of fungal communities in humans |
| Q47818880 | Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches. |
| Q35208886 | Conducting a microbiome study |
| Q64244932 | Conjunctival microbiome changes associated with fungal keratitis: metagenomic analysis |
| Q39123280 | Contact, Collaboration, and Conflict: Signal Integration of Syk-Coupled C-Type Lectin Receptors |
| Q90474825 | Contrasting Strategies: Human Eukaryotic Versus Bacterial Microbiome Research |
| Q38928541 | Critical Issues in Mycobiota Analysis |
| Q93088868 | DNA extraction and amplicon production strategies deeply inf luence the outcome of gut mycobiome studies |
| Q42143231 | Dectin-1 Exerts Dual Control in the Gut. |
| Q35767926 | Dectin-1 Polymorphism: A Genetic Disease Specifier in Autism Spectrum Disorders? |
| Q40126299 | Dectin-1 embraces Candida glabrata. |
| Q47915134 | Dectin-1 gene polymorphism is associated with susceptibility to nonspecific digestive disorders and cytokine expression in rabbits |
| Q36396796 | Dectin-1 is not required for controlling Candida albicans colonization of the gastrointestinal tract |
| Q36581279 | Dectin-1 is required for resistance to coccidioidomycosis in mice |
| Q34638032 | Dectin-1 regulates IL-10 production via a MSK1/2 and CREB dependent pathway and promotes the induction of regulatory macrophage markers |
| Q34736394 | Dectin-1-dependent LC3 recruitment to phagosomes enhances fungicidal activity in macrophages. |
| Q36046395 | Dectin-3 Deficiency Promotes Colitis Development due to Impaired Antifungal Innate Immune Responses in the Gut. |
| Q26851835 | Defining dysbiosis and its influence on host immunity and disease |
| Q36116759 | Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent Mechanism |
| Q42223966 | Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? |
| Q91724965 | Dependence of Colonization of the Large Intestine by Candida on the Treatment of Crohn's Disease |
| Q35748693 | Diagnostic and Prognostic Microbial Biomarkers in Inflammatory Bowel Diseases |
| Q87453794 | Diagnostic potential of antibody titres against Candida cell wall β-glucan in Kawasaki disease |
| Q34435517 | Diet and the intestinal microbiome: associations, functions, and implications for health and disease |
| Q37005642 | Diet-dependent, microbiota-independent regulation of IL-10-producing lamina propria macrophages in the small intestine. |
| Q28486281 | Differential adaptation of Candida albicans in vivo modulates immune recognition by dectin-1 |
| Q35918461 | Distinct stages during colonization of the mouse gastrointestinal tract by Candida albicans |
| Q35547552 | Dysbiosis of fungal microbiota in the intestinal mucosa of patients with colorectal adenomas |
| Q92526760 | Dysregulation of Intestinal Epithelial Cell RIPK Pathways Promotes Chronic Inflammation in the IBD Gut |
| Q47105946 | Early-Life Human Microbiota Associated With Childhood Allergy Promotes the T Helper 17 Axis in Mice |
| Q27693228 | Effect of barrier microbes on organ-based inflammation |
| Q27024742 | Effector and memory T cell responses to commensal bacteria |
| Q64085988 | Effects of a Novel Probiotic Combination on Pathogenic Bacterial-Fungal Polymicrobial Biofilms |
| Q55154729 | Emerging Mechanisms of Innate Immunity and Their Translational Potential in Inflammatory Bowel Disease. |
| Q35058372 | Emerging roles of the microbiome in cancer |
| Q93347337 | Enteric fungal microbiota dysbiosis and ecological alterations in colorectal cancer |
| Q58776759 | Enterobacteriaceae are essential for the modulation of colitis severity by fungi |
| Q38366954 | Epidemiology and risk factors for IBD. |
| Q49479077 | Eukaryotes in the gut microbiota in myalgic encephalomyelitis/chronic fatigue syndrome |
| Q35070680 | Evaluating the impact of different sequence databases on metaproteome analysis: insights from a lab-assembled microbial mixture |
| Q38870576 | Evaluation of Malassezia and Common Fungal Pathogens in Subtypes of Chronic Rhinosinusitis |
| Q51543850 | Evaluation of gastrointestinal leakage using serum (1→3)-β-D-glucan in a Clostridium difficile murine model. |
| Q35618798 | Experimental Models of Inflammatory Bowel Diseases |
| Q35766366 | Fecal microbiota analysis: an overview of sample collection methods and sequencing strategies |
| Q55325579 | Flexible Signaling of Myeloid C-Type Lectin Receptors in Immunity and Inflammation. |
| Q38692272 | Forgotten fungi-the gut mycobiome in human health and disease |
| Q36778793 | Fungal Chitin Induces Trained Immunity in Human Monocytes during Cross-talk of the Host with Saccharomyces cerevisiae. |
| Q37118457 | Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients |
| Q37642262 | Fungal ITS1 Deep-Sequencing Strategies to Reconstruct the Composition of a 26-Species Community and Evaluation of the Gut Mycobiota of Healthy Japanese Individuals |
| Q39218242 | Fungal Microbiota Profile in Newly Diagnosed Treatment-naïve Children with Crohn's Disease |
| Q47556988 | Fungal Microbiota in Chronic Airway Inflammatory Disease and Emerging Relationships with the Host Immune Response |
| Q35666254 | Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease. |
| Q91736512 | Fungal Translocation Is Associated with Immune Activation and Systemic Inflammation in Treated HIV |
| Q37126219 | Fungal cell wall dynamics and infection site microenvironments: signal integration and infection outcome |
| Q57807154 | Fungal dysbiosis predicts the diagnosis of pediatric Crohn's disease |
| Q39366659 | Fungal dysbiosis: immunity and interactions at mucosal barriers. |
| Q43406209 | Fungal intestinal flora in the development of Crohn's disease |
| Q35914203 | Fungal microbiota dysbiosis in IBD. |
| Q38063202 | Fungal pathogens-a sweet and sour treat for toll-like receptors |
| Q92219510 | Fungal-Bacterial Interactions in Health and Disease |
| Q90576117 | Fungi accelerate pancreatic cancer |
| Q46267304 | Fungi in Gastrointestinal Tracts of Human and Mice: from Community to Functions |
| Q34972317 | Fungi of the murine gut: episodic variation and proliferation during antibiotic treatment |
| Q46311213 | Gallbladder-derived surfactant protein D regulates gut commensal bacteria for maintaining intestinal homeostasis |
| Q90221222 | Gastrointestinal microbiota alteration induced by Mucor circinelloides in a murine model |
| Q37387151 | Gradual Changes of Gut Microbiota in Weaned Miniature Piglets. |
| Q38311200 | Gut dysbiosis promotes M2 macrophage polarization and allergic airway inflammation via fungi-induced PGE₂. |
| Q58756108 | Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection |
| Q35534964 | Gut fungal microbiota: the Yin and Yang of inflammatory bowel disease |
| Q39458190 | Gut microbiota and IBD: causation or correlation? |
| Q61445387 | Gut microbiota density influences host physiology and is shaped by host and microbial factors |
| Q36002545 | Gut microbiota: an Indicator to Gastrointestinal Tract Diseases |
| Q99622569 | Gut mycobiome and its interaction with diet, gut bacteria and alzheimer's disease markers in subjects with mild cognitive impairment: A pilot study |
| Q59355588 | HSV1/2 Genital Infection in Mice Cause Reversible Delayed Gastrointestinal Transit: A Model for Enteric Myopathy |
| Q42374719 | High-Fat Diet Changes Fungal Microbiomes and Interkingdom Relationships in the Murine Gut. |
| Q36351062 | Homeostatic Immunity and the Microbiota |
| Q38663887 | Host Genetics and Gut Microbiome: Challenges and Perspectives |
| Q38053751 | Host translation at the nexus of infection and immunity |
| Q47572862 | Host-microbe interactions: commensal fungi in the gut. |
| Q95840390 | Host-microbiota interactions in immune-mediated diseases |
| Q89475561 | Host-microbiota interactions in inflammatory bowel disease |
| Q97418191 | How being synanthropic affects the gut bacteriome and mycobiome: comparison of two mouse species with contrasting ecologies |
| Q46318762 | Human genetic variation and the gut microbiome in disease |
| Q38953696 | Human intestinal epithelial cells respond to β-glucans via Dectin-1 and Syk. |
| Q35202656 | Humoral immunity links Candida albicans infection and celiac disease |
| Q35746147 | Hypoxia and Temperature Regulated Morphogenesis in Candida albicans |
| Q93381993 | IL-12, IL-23 and IL-17 in IBD: immunobiology and therapeutic targeting |
| Q26799351 | IL-17-Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans |
| Q40745898 | IL-17C is required for lethal inflammation during systemic fungal infection |
| Q35044349 | Identification accuracy and diversity reproducibility associated with internal transcribed spacer-based fungal taxonomic library preparation. |
| Q50000073 | Identification of fungi in shotgun metagenomics datasets |
| Q40620612 | Identification of three yeast species using the conventional and internal transcribed spacer region sequencing methods as first or second global record from human superficial infections |
| Q35847333 | Immune Interactions with Pathogenic and Commensal Fungi: A Two-Way Street |
| Q35755268 | Immune Responses to Intestinal Microbes in Inflammatory Bowel Diseases |
| Q38590007 | Immune defence against Candida fungal infections |
| Q33752362 | Immunity against fungi |
| Q39076987 | Immunity to Commensal Fungi: Detente and Disease |
| Q41839558 | Immunological Consequences of Intestinal Fungal Dysbiosis. |
| Q38134739 | Immunomodulation of Fungal β-Glucan in Host Defense Signaling by Dectin-1. |
| Q27027636 | Immunopathology of inflammatory bowel disease |
| Q40107600 | Immunotherapeutic approaches to treatment of fungal diseases. |
| Q58130673 | Increased T helper type 17 response to pathogen stimulation in patients with primary sclerosing cholangitis |
| Q35770936 | Indoleamine 2,3-Dioxygenase Is Involved in the Inflammation Response of Corneal Epithelial Cells to Aspergillus fumigatus Infections |
| Q36278070 | Infant fungal communities: current knowledge and research opportunities |
| Q36597803 | Inflammation and colorectal cancer: colitis-associated neoplasia |
| Q35807983 | Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn's Disease |
| Q28066899 | Influence of Saccharomyces boulardii CNCM I-745on the gut-associated immune system |
| Q35061717 | Influences of the microbiome on the early origins of allergic asthma |
| Q92482391 | Ingestion of Non-digestible Carbohydrates From Plant-Source Foods and Decreased Risk of Colorectal Cancer: A Review on the Biological Effects and the Mechanisms of Action |
| Q35589587 | Innate Defense against Fungal Pathogens |
| Q57172513 | Innate and adaptive immune responses to fungi in the airway |
| Q35069164 | Innate lymphoid cells: new players in IL-17-mediated antifungal immunity |
| Q64102240 | Interactions Between the Gut Microbiota and the Host Innate Immune Response Against Pathogens |
| Q90726659 | Interactions of commensal and pathogenic microorganisms with the mucus layer in the colon |
| Q26752528 | Interleukin-22 in Graft-Versus-Host Disease after Allogeneic Stem Cell Transplantation |
| Q36711467 | Interleukin-4- and interleukin-13-mediated alternatively activated macrophages: roles in homeostasis and disease. |
| Q28081406 | International Union of Basic and Clinical Pharmacology. XCVI. Pattern recognition receptors in health and disease |
| Q92132680 | Intestinal Flora and Disease Mutually Shape the Regional Immune System in the Intestinal Tract |
| Q92951800 | Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis |
| Q58581113 | Intestinal bacterial biofilms modulate mucosal immune responses |
| Q35403015 | Intestinal colonization by Candida albicans alters inflammatory responses in Bruton's tyrosine kinase-deficient mice |
| Q36451342 | Intestinal commensal microbes as immune modulators |
| Q91000447 | Intestinal epithelial cells and T cells differentially recognize and respond to Candida albicans yeast and hypha |
| Q95660615 | Intestinal fungi are causally implicated in microbiome assembly and immune development in mice |
| Q41661762 | Intestinal fungi contribute to development of alcoholic liver disease. |
| Q33718887 | Intestinal microbiome and lymphoma development |
| Q27003192 | Intestinal microbiota pathogenesis and fecal microbiota transplantation for inflammatory bowel disease |
| Q26741017 | Intestinal microbiota transplant - current state of knowledge |
| Q38525376 | Intracellular survival of Candida glabrata in macrophages: immune evasion and persistence |
| Q54245309 | Investigating Colonization of the Healthy Adult Gastrointestinal Tract by Fungi. |
| Q40066779 | Investigation of faecal volatile organic metabolites as novel diagnostic biomarkers in inflammatory bowel disease. |
| Q35057664 | Irritable bowel syndrome, inflammatory bowel disease and the microbiome. |
| Q31151211 | Kingdom-agnostic metagenomics and the importance of complete characterization of enteric microbial communities |
| Q36206938 | Kluyveromyces marxianus and Saccharomyces boulardii Induce Distinct Levels of Dendritic Cell Cytokine Secretion and Significantly Different T Cell Responses In Vitro |
| Q47116608 | LC3-Associated Phagocytosis Is Required for Dendritic Cell Inflammatory Cytokine Response to Gut Commensal Yeast Saccharomyces cerevisiae. |
| Q46447435 | Lactate signalling regulates fungal β-glucan masking and immune evasion |
| Q38588803 | Learning from other diseases: protection and pathology in chronic fungal infections |
| Q34348097 | Lymphoma caused by intestinal microbiota |
| Q91615855 | Macrophage interactions with fungi and bacteria in inflammatory bowel disease |
| Q99707958 | Macrophages Maintain Epithelium Integrity by Limiting Fungal Product Absorption |
| Q62746584 | Malassezia Is Associated with Crohn's Disease and Exacerbates Colitis in Mouse Models |
| Q50129416 | Mechanisms of angiogenesis in microbe-regulated inflammatory and neoplastic conditions |
| Q26752423 | Mechanistic Insights into the Role of C-Type Lectin Receptor/CARD9 Signaling in Human Antifungal Immunity |
| Q37393664 | Medical mycology and fungal immunology: new research perspectives addressing a major world health challenge |
| Q24288894 | Metagenomics for pathogen detection in public health |
| Q84953153 | Metagenomics with guts |
| Q34465478 | Microarray analysis reveals global modulation of endogenous retroelement transcription by microbes. |
| Q47156352 | Microbial Ecology along the Gastrointestinal Tract |
| Q46257092 | Microbial Insights into Asthmatic Immunopathology. A Forward-Looking Synthesis and Commentary. |
| Q35119984 | Microbial activities and intestinal homeostasis: A delicate balance between health and disease |
| Q98463781 | Microbial modulation of intestinal T helper cell responses and implications for disease and therapy |
| Q64114415 | Microbiome Dependent Regulation of T and Th17 Cells in Mucosa |
| Q35277854 | Microbiota control of a tryptophan-AhR pathway in disease tolerance to fungi |
| Q50263790 | Microbiota in digestive cancers: our new partner? |
| Q90269186 | Microbiota: a novel regulator of pain |
| Q89965223 | Milk Microbiota: What Are We Exactly Talking About? |
| Q35235355 | Modulation of immune development and function by intestinal microbiota. |
| Q34813691 | Modulation of post-antibiotic bacterial community reassembly and host response by Candida albicans |
| Q90638450 | Modulation of the fungal mycobiome is regulated by the chitin-binding receptor FIBCD1 |
| Q52699529 | Molecular basis for intestinal mucin recognition by galectin-3 and C-type lectins. |
| Q37341312 | Molecular detection of bacterial contamination in gnotobiotic rodent units |
| Q26741117 | Mucosal Interactions between Genetics, Diet, and Microbiome in Inflammatory Bowel Disease |
| Q84446375 | Mucosal immunology: Don't forget our fungal friends |
| Q37734574 | Mucus enhances gut homeostasis and oral tolerance by delivering immunoregulatory signals |
| Q89835212 | Multidirectional Pharma-Toxicological Study on Harpagophytum procumbens DC. ex Meisn.: An IBD-Focused Investigation |
| Q38137645 | Murine models of Candida gastrointestinal colonization and dissemination |
| Q93164681 | Mycobiome in the Gut: A Multiperspective Review |
| Q35609441 | Mycobiome: Approaches to analysis of intestinal fungi |
| Q34447163 | Mycobiota in gastrointestinal diseases |
| Q92967817 | Myeloid C-type lectin receptors in skin/mucoepithelial diseases and tumors |
| Q36552047 | N-acetylglucosamine (GlcNAc) functions in cell signaling |
| Q33911333 | NOX2-dependent regulation of inflammation |
| Q36096377 | Neutrophils Do Not Express IL-17A in the Context of Acute Oropharyngeal Candidiasis. |
| Q37658313 | New evidences on the altered gut microbiota in autism spectrum disorders |
| Q26746024 | Next-Generation Sequencing in the Mycology Lab |
| Q38723919 | Novel Strategies for Applied Metagenomics. |
| Q34497633 | Obesity changes the human gut mycobiome |
| Q92811631 | On Commensalism of Candida |
| Q35594296 | Oral mixture of autologous colon-extracted proteins for the Crohn's disease: A double-blind trial |
| Q35120262 | Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi |
| Q34230506 | Oral-resident natural Th17 cells and γδ T cells control opportunistic Candida albicans infections |
| Q40394443 | Orally delivered β-glucans aggravate dextran sulfate sodium (DSS)-induced intestinal inflammation |
| Q54218424 | Orchestration of intestinal homeostasis and tolerance by group 3 innate lymphoid cells. |
| Q49795904 | Organ-specific mechanisms linking innate and adaptive antifungal immunity |
| Q34175500 | Overview of vertebrate animal models of fungal infection. |
| Q93182051 | Ovine C-type lectin receptor hFc-fusion protein library - A novel platform to screen for host-pathogen interactions |
| Q38750548 | Pathogenesis of Inflammatory Bowel Disease and Recent Advances in Biologic Therapies. |
| Q35450411 | Pathogenic fungi regulate immunity by inducing neutrophilic myeloid-derived suppressor cells |
| Q34305895 | Pathogenic simian immunodeficiency virus infection is associated with expansion of the enteric virome |
| Q38270905 | Pattern recognition receptors in antifungal immunity |
| Q52664258 | Pattern recognition receptors in fungal immunity. |
| Q35925933 | Peripheral Lymphoid Volume Expansion and Maintenance Are Controlled by Gut Microbiota via RALDH+ Dendritic Cells |
| Q57055918 | Polymorphisms in receptors involved in opsonic and non-opsonic phagocytosis and the risk of infection in oncohematological patients |
| Q52889323 | Polymorphisms of the immune-modulating receptor dectin-1 in pigs: their functional influence and distribution in pig populations. |
| Q35096915 | Probiotic actions on diseases: implications for therapeutic treatments |
| Q56395519 | Profiling of Bacterial and Fungal Microbial Communities in Cystic Fibrosis Sputum Using RNA |
| Q92229934 | Profound mycobiome differences between segregated mouse colonies do not influence Th17 responses to a newly introduced gut fungal commensal |
| Q89958108 | Raman-activated sorting of antibiotic-resistant bacteria in human gut microbiota |
| Q96953619 | Receptors Mediating Host-Microbiota Communication in the Metaorganism: The Invertebrate Perspective |
| Q39443984 | Regulation of inflammation by microbiota interactions with the host. |
| Q35079805 | Regulatory circuits that enable proliferation of the fungus Candida albicans in a mammalian host |
| Q35134829 | Relationship between gut microbiota and development of T cell associated disease |
| Q43113813 | Reply to comment on: Dietary yeasts reduce inflammation in central nervous system via microflora |
| Q37179289 | Resident commensals shaping immunity |
| Q46284784 | Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management. |
| Q35278095 | Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease. |
| Q39196104 | Role of bacterial lipopolysaccharide in enhancing host immune response to Candida albicans |
| Q56591587 | Role of mannose-binding lectin in intestinal homeostasis and fungal elimination |
| Q27317611 | Role of the C-type lectin receptors MCL and DCIR in experimental colitis |
| Q33752553 | Role of the microbiota in immunity and inflammation |
| Q33906911 | Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches |
| Q35302843 | SIGNR3-dependent immune regulation by Lactobacillus acidophilus surface layer protein A in colitis |
| Q39033321 | SIGNing a symbiotic treaty with gut microbiota |
| Q26865497 | Shaping the oral mycobiota: interactions of opportunistic fungi with oral bacteria and the host |
| Q38170551 | Signalling C-type lectin receptors, microbial recognition and immunity. |
| Q37062344 | Skin Immunity to Candida albicans |
| Q34505062 | Small RNAs from plants, bacteria and fungi within the order Hypocreales are ubiquitous in human plasma |
| Q28259100 | Small intestinal fungal overgrowth |
| Q37380773 | Sodium methyldithiocarbamate exerts broad inhibition of cellular signaling and expression of effector molecules of inflammation |
| Q37092848 | Striking a balance: fungal commensalism versus pathogenesis |
| Q58122572 | Structure Dependent-Immunomodulation by Sugar Beet Arabinans via a SYK Tyrosine Kinase-Dependent Signaling Pathway |
| Q35044638 | Structure and function of the human skin microbiome |
| Q90283978 | Studying fungal pathogens of humans and fungal infections: fungal diversity and diversity of approaches |
| Q38184870 | Symbiosis as a general principle in eukaryotic evolution |
| Q26797310 | Systems Level Dissection of Candida Recognition by Dectins: A Matter of Fungal Morphology and Site of Infection |
| Q57146421 | TLR4, TLR9, and NLRP3 in biliary epithelial cells of primary sclerosing cholangitis: relationship with clinical characteristics |
| Q37157676 | Tailored immunity at mucosae |
| Q37015604 | The C-Type Lectin Receptor SIGNR3 Binds to Fungi Present in Commensal Microbiota and Influences Immune Regulation in Experimental Colitis |
| Q39260239 | The Cell Biology of the Trichosporon-Host Interaction |
| Q90223876 | The Dysbiosis and Inter-Kingdom Synergy Model in Oropharyngeal Candidiasis, a New Perspective in Pathogenesis |
| Q35880704 | The Effect of Lactobacillus casei 32G on the Mouse Cecum Microbiota and Innate Immune Response Is Dose and Time Dependent |
| Q38639804 | The Fungal Frontier: A Comparative Analysis of Methods Used in the Study of the Human Gut Mycobiome. |
| Q36271354 | The Fungal Mycobiome and Its Interaction with Gut Bacteria in the Host. |
| Q36346259 | The Gut Microbiome: Connecting Spatial Organization to Function |
| Q57492072 | The Gut Microbiota in the Pathogenesis and Therapeutics of Inflammatory Bowel Disease |
| Q37521076 | The HOG pathway is critical for the colonization of the mouse gastrointestinal tract by Candida albicans |
| Q47711287 | The Human Mucosal Mycobiome and Fungal Community Interactions |
| Q36034914 | The Impact of Lactobacillus casei on the Composition of the Cecal Microbiota and Innate Immune System Is Strain Specific |
| Q55385103 | The Intestinal Mycobiota in Wild Zebrafish Comprises Mainly Dothideomycetes While Saccharomycetes Predominate in Their Laboratory-Reared Counterparts. |
| Q28067461 | The Multibiome: The Intestinal Ecosystem's Influence on Immune Homeostasis, Health, and Disease |
| Q52664476 | The Mycobiome: A Neglected Component in the Microbiota-Gut-Brain Axis. |
| Q93186295 | The Potential Role of Gut Mycobiome in Irritable Bowel Syndrome |
| Q91303785 | The Relationship of Candida albicans with the Oral Bacterial Microbiome in Health and Disease |
| Q26752567 | The Role of Autophagy-Related Proteins in Candida albicans Infections |
| Q39308885 | The Role of Carrageenan and Carboxymethylcellulose in the Development of Intestinal Inflammation |
| Q36786137 | The Role of Dectin-2 for Host Defense Against Disseminated Candidiasis |
| Q38328470 | The adaptor CARD9 is required for adaptive but not innate immunity to oral mucosal Candida albicans infections |
| Q38441242 | The effect of host genetics on the gut microbiome |
| Q34727901 | The emerging world of the fungal microbiome |
| Q90355998 | The evidence for fungus in Crohn's disease pathogenesis |
| Q26853435 | The ground state of innate immune responsiveness is determined at the interface of genetic, epigenetic, and environmental influences |
| Q38884056 | The gut microbiota and inflammatory bowel diseases |
| Q46253527 | The gut mycobiome of the Human Microbiome Project healthy cohort. |
| Q92063098 | The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases |
| Q36153323 | The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. |
| Q35408304 | The human mycobiome |
| Q28295636 | The human mycobiome in health and disease |
| Q38293766 | The innate immune system and inflammatory bowel disease. |
| Q26745700 | The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions |
| Q35082308 | The lung mycobiome: an emerging field of the human respiratory microbiome. |
| Q91749460 | The mammalian mycobiome: A complex system in a dynamic relationship with the host |
| Q34311522 | The microbial basis of inflammatory bowel diseases |
| Q35215942 | The microbial eukaryote Blastocystis is a prevalent and diverse member of the healthy human gut microbiota. |
| Q36069070 | The microbiome and innate immunity |
| Q38182899 | The microbiome and psoriatic arthritis |
| Q38949256 | The microbiome in asthma |
| Q39001907 | The microbiome-metabolome crosstalk in the pathogenesis of respiratory fungal diseases |
| Q33806817 | The microbiota in inflammatory bowel disease: current and therapeutic insights |
| Q37634456 | The mycobiome of the human urinary tract: potential roles for fungi in urology |
| Q90159677 | The mycobiota of the human body: a spark can start a prairie fire |
| Q35096262 | The mycobiota: interactions between commensal fungi and the host immune system. |
| Q35277785 | The potential impact of the pulmonary microbiome on immunopathogenesis of Aspergillus-related lung disease |
| Q36906422 | The regulatory power of glycans and their binding partners in immunity |
| Q34700824 | The response of human macrophages to β-glucans depends on the inflammatory milieu. |
| Q36147431 | The role of pattern recognition receptors in the innate recognition of Candida albicans |
| Q47563895 | The triune of intestinal microbiome, genetics and inflammatory status and its impact on the healing of lower gastrointestinal anastomoses |
| Q28660380 | The virome in mammalian physiology and disease |
| Q47138923 | The yeast form of the fungus Candida albicans promotes persistence in the gut of gnotobiotic mice |
| Q58713172 | There was collusion: Microbes in inflammatory bowel disease |
| Q47565602 | Through the Scope Darkly: The Gut Mycobiome Comes into Focus |
| Q89560976 | Time of Feeding Alters Obesity-Associated Parameters and Gut Bacterial Communities, but Not Fungal Populations, in C57BL/6 Male Mice |
| Q97905226 | Tissue-resident memory Th17 cells maintain stable fungal commensalism in the oral mucosa |
| Q34734628 | Topographic diversity of fungal and bacterial communities in human skin |
| Q38171924 | Towards personalized care in IBD. |
| Q45760347 | Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22. |
| Q43499673 | Tuning of skin immunity by skin commensal bacteria |
| Q92071463 | Unaltered Fungal Burden and Lethality in Human CEACAM1-Transgenic Mice During Candida albicans Dissemination and Systemic Infection |
| Q27002380 | Upper gastrointestinal microbiota and digestive diseases |
| Q52579441 | Urbanization and the gut microbiota in health and inflammatory bowel disease. |
| Q34384544 | Use of animal models in elucidating disease pathogenesis in IBD. |
| Q35040842 | Using Bayesian modelling to investigate factors governing antibiotic-induced Candida albicans colonization of the GI tract |
| Q35905803 | Viral immunity. Transkingdom control of viral infection and immunity in the mammalian intestine |
| Q34585227 | Waiting for the human intestinal Eukaryotome |
| Q34376721 | Yeast communities of diverse Drosophila species: comparison of two symbiont groups in the same hosts |
| Q33590266 | Yeast modulation of human dendritic cell cytokine secretion: an in vitro study |
| Q92859509 | mSphere of Influence: the Mycobiota in Human Health and Disease |
| Q47606694 | β-Glucans in food modify colonic microflora by inducing antimicrobial protein, calprotectin, in a Dectin-1-induced-IL-17F-dependent manner. |
| Q37525770 | β-glucan Exposure on the Fungal Cell Wall Tightly Correlates with Competitive Fitness of Candida Species in the Mouse Gastrointestinal Tract |
Search more.